Rhumbline Advisers Cuts Stake in Vir Biotechnology, Inc. (NASDAQ:VIR)
Rhumbline Advisers reduced its stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 4.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 226,649 shares of the company’s stock after selling 10,032 shares during the period. Rhumbline Advisers’ holdings […]
Rhumbline Advisers reduced its stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 4.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 226,649 shares of the company’s stock after selling 10,032 shares during the period. Rhumbline Advisers’ holdings […]
